Emtriva
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted
- Valid from
- undated
- Valid until
- still holds
- Published
- 2018-02-27
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-10 · its source page states the value and the date
- Confidence
- 0.80
Sources
“Our portfolio of marketed products includes AmBisome ® , Atripla ® , Biktarvy ® , Cayston ® , Complera ® /Eviplera ® , Descovy ® , Emtriva ® , Epclusa ® ,”— what the page says, read 2026-11-10
- https://www.sec.gov/Archives/edgar/data/882095/000088209518000008/a2017form10-k.htm
- https://www.wikidata.org/wiki/Q663596
Cite this claim
Plain text
AsOf. "Gilead Sciences produces: Emtriva", undated. Claim clm_952713EE6AA9, https://asof.is/claim/clm_952713EE6AA9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209518000008/a2017form10-k.htm.
APA
AsOf. (n.d.). Gilead Sciences produces: Emtriva (undated) [Record clm_952713EE6AA9]. Retrieved November 10, 2026, from https://asof.is/claim/clm_952713EE6AA9 (source: https://www.sec.gov/Archives/edgar/data/882095/000088209518000008/a2017form10-k.htm)
BibTeX
@misc{asof_clm_952713EE6AA9,
author = {AsOf},
title = {Gilead Sciences produces: Emtriva},
howpublished = {\url{https://asof.is/claim/clm_952713EE6AA9}},
note = {Claim clm\_952713EE6AA9, undated; source: https://www.sec.gov/Archives/edgar/data/882095/000088209518000008/a2017form10-k.htm},
urldate = {2026-11-10}
}On the record
/claim/clm_952713EE6AA9.md/v1/claims/clm_952713EE6AA9submit a correction